Y-mAbs Therapeutics, Inc. $YMAB Stake Lifted by Acorn Capital Advisors LLC
MarketBeat
Acorn Capital Advisors LLC grew its holdings in Y-mAbs Therapeutics, Inc. (NASDAQ:YMAB - Free Report) by 13.1% during the first quarter, according to the company in its most recent filing with the SEC. The fund owned 3,235,387 shares of the company's stock after acquiring an additional 373,562 shar
NASDAQ:YMAB